Cargando…
Tranexamic acid use during total hip arthroplasty: A single center retrospective analysis
BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic agent that has shown promise in reducing blood loss during total hip arthroplasty (THA). Several studies have reported side effects of high-dose TXA administration, including myocardial infarction (MI), thromboembolic events, and seizures. The...
Autores principales: | Stoicea, Nicoleta, Moran, Kenneth, Mahmoud, Abdel-Rasoul, Glassman, Andrew, Ellis, Thomas, Ryan, John, Granger, Jeffrey, Joseph, Nicholas, Salon, Nathan, Ackermann, Wiebke, Rogers, Barbara, Niermeyer, Weston, Bergese, Sergio D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392984/ https://www.ncbi.nlm.nih.gov/pubmed/29794747 http://dx.doi.org/10.1097/MD.0000000000010720 |
Ejemplares similares
-
Perioperative Outcome of Dyssomnia Patients on Chronic Methylphenidate Use
por: Stoicea, Nicoleta, et al.
Publicado: (2014) -
The effect of tranexamic acid on hidden blood loss in total hip arthroplasty
por: Akti, Sefa, et al.
Publicado: (2022) -
Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center
por: Fiorda Diaz, Juan, et al.
Publicado: (2022) -
The efficacy of topical tranexamic acid in total hip arthroplasty: a meta-analysis
por: Chen, Shubiao, et al.
Publicado: (2016) -
Application of dexamethasone combined with tranexamic acid in perioperative period of total hip arthroplasty
por: Li, Fulin, et al.
Publicado: (2022)